Literature DB >> 22353385

Association of circulating levels of asymmetric dimethylarginine (ADMA) with carotid intima-media thickness: evidence from 6168 participants.

Yongyi Bai1, Lan Sun, Lida Du, Tiantai Zhang, Wenyu Xin, Xi Lan, Guanhua Du.   

Abstract

BACKGROUND: Epidemiologic investigations have linked the circulating levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), to carotid intima-media thickness (IMT). However, these studies result in various extent of relation between ADMA and IMT, the conclusions were inconsistent, and the precise relationship is therefore under debate. The objective of this systematic review and meta-analysis is to provide an overview of the relevant studies evaluating the association of levels of ADMA with carotid IMT and to gain more robust estimate of the relationship.
METHODS: Studies were identified through PubMed, Cochrane Library, Embase, reviews, and reference lists of relevant papers. Weighted means of the correlation coefficient (R) and partial correlation coefficient (PR) were calculated for relations by using random-effect models.
RESULTS: 22 studies with a total of 6168 subjects were included in our meta-analysis. In an overall pooled estimate of correlation coefficient (R), levels of ADMA were significantly related to carotid IMT (pooled R: 0.29; 95% confidence interval [CI]: 0.20-0.38, P<0.001). Pooled estimate of partial correlation coefficient (PR) also resulted in a significant association of ADMA with carotid IMT (pooled PR: 0.21; 95% CI: 0.14-0.29; P<0.001). Furthermore, subgroup analysis found that the relation between ADMA and IMT was stronger in patients with chronic kidney diseases (CKDs) than that in subject with normal renal function.
CONCLUSIONS: Circulating levels of ADMA were positively related to carotid IMT, especially in patients with CKDs. The findings need confirmation in longitudinal and interventional studies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22353385     DOI: 10.1016/j.arr.2012.02.003

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  14 in total

1.  Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Authors:  Giovanni Tripepi; Barbara Kollerits; Daniela Leonardis; Mahamut Ilker Yilmaz; Maurizio Postorino; Danilo Fliser; Francesca Mallamaci; Florian Kronenberg; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

2.  Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.

Authors:  Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Karen L Furie; Jonathan Rosand; Natalia S Rost
Journal:  Atherosclerosis       Date:  2015-03-02       Impact factor: 5.162

3.  The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-β-signalling pathways in an SMC/EC-crosstalk-associated manner.

Authors:  Yongyi Bai; Jingrong Wang; Ying Chen; Tingting Lv; Xiaojian Wang; Chunlei Liu; Hao Xue; Kunlun He; Lan Sun
Journal:  Basic Res Cardiol       Date:  2021-09-21       Impact factor: 17.165

4.  Prospectively Collected Cardiovascular Biomarkers and White Matter Hyperintensity Volume in Ischemic Stroke Patients.

Authors:  Pamela M Rist; Nancy R Cook; Julie E Buring; Kathryn M Rexrode; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-02-22       Impact factor: 2.136

5.  Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients.

Authors:  Aysegul Kudu Cobanoglu; Ozkan Gungor; Fatih Kircelli; Ekrem Altunel; Gulay Asci; Sureyya Suha Ozbek; Huseyin Toz; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2012-12-05       Impact factor: 2.370

6.  High dietary fructose does not exacerbate the detrimental consequences of high fat diet on basilar artery function.

Authors:  H Z Toklu; J Muller-Delp; Y Sakaraya; S Oktay; N Kirichenko; M Matheny; C S Carter; D Morgan; K Y E Strehler; N Tumer; P J Scarpace
Journal:  J Physiol Pharmacol       Date:  2016-04       Impact factor: 3.011

Review 7.  Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.

Authors:  Mohammad Badran; Saeid Golbidi; Najib Ayas; Ismail Laher
Journal:  Sleep Disord       Date:  2015-05-06

8.  L-Arginine and SDMA Serum Concentrations Are Associated with Subclinical Atherosclerosis in the Study of Health in Pomerania (SHIP).

Authors:  Martin Bahls; Nele Friedrich; Dorothee Atzler; Stephan B Felix; Matthias A Nauck; Rainer H Böger; Henry Völzke; Edzard Schwedhelm; Marcus Dörr
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 9.  Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.

Authors:  Peter Willeit; Daniel F Freitag; Jari A Laukkanen; Susmita Chowdhury; Reeta Gobin; Manuel Mayr; Emanuele Di Angelantonio; Rajiv Chowdhury
Journal:  J Am Heart Assoc       Date:  2015-05-28       Impact factor: 5.501

Review 10.  Asymmetric dimethyarginine as marker and mediator in ischemic stroke.

Authors:  Shufen Chen; Na Li; Milani Deb-Chatterji; Qiang Dong; Jan T Kielstein; Karin Weissenborn; Hans Worthmann
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.